Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-02-08

Clinical Trial Update: Duloxetine for Major Depression in Peri-/Postmenopausal Women [Phase 4]

View source ↗

Summary

Phase 4 trial update of duloxetine for major depressive disorder in peri- and postmenopausal women.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Duloxetine (DULOXETINE)

Snippet

Sponsor: Hamilton Health Sciences Corporation | Conditions: Major Depressive Disorder | Phase 4 | Status: UNKNOWN